Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

AXIOM IMPLANT ?5.2 x 8.0: medical device reports filed with FDA

783 reports name it, 2021–2026. Manufacturer given most often on reports: Anthogyr. Product code DZE.

783
device reports naming the brand
0% of all MAUDE reports · about 147 a year
118
reports, 12 months to August 2026
147 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 783 reports that name the brand "AXIOM IMPLANT ?5.2 x 8.0" (endosseous dental implant), received between March 2021 and August 2026; the manufacturer given most often on reports is Anthogyr. Spellings of one product vary from report to report.

118 reports arrived in the 12 months to August 2026, down 20% from 147 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (84%), loss of osseointegration (15.1%) and fracture (2.4%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02040Sep 2021: 2Oct 2021: 8Nov 2021: 10Dec 2021: 82022Jan 2022: 40Feb 2022: 17Mar 2022: 4Apr 2022: 4May 2022: 3Jun 2022: 18Jul 2022: 11Aug 2022: 8Sep 2022: 14Oct 2022: 13Nov 2022: 11Dec 2022: 222023Jan 2023: 3Feb 2023: 4Mar 2023: 2Apr 2023: 6May 2023: 10Jun 2023: 17Jul 2023: 21Aug 2023: 7Sep 2023: 23Oct 2023: 16Nov 2023: 22Dec 2023: 192024Jan 2024: 13Feb 2024: 20Mar 2024: 9Apr 2024: 8May 2024: 13Jun 2024: 11Jul 2024: 6Aug 2024: 6Sep 2024: 8Oct 2024: 10Nov 2024: 10Dec 2024: 82025Jan 2025: 6Feb 2025: 16Mar 2025: 16Apr 2025: 9May 2025: 0Jun 2025: 39Jul 2025: 9Aug 2025: 16Sep 2025: 20Oct 2025: 9Nov 2025: 6Dec 2025: 152026Jan 2026: 15Feb 2026: 8Mar 2026: 19Apr 2026: 11May 2026: 2Jun 2026: 5Jul 2026: 5Aug 2026: 3

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0831652021: 11720212022: 16520222023: 15020232024: 12220242025: 16120252026: 682026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%783
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%783
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate65884%62.8%
Loss of osseointegration11815.1%22.4%
Fracturea broken bone192.4%1.6%
Separation failure10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis8410.7%
Painpain, site not specified395%
Inflammationinflammation334.2%
Swelling/ edema243.1%
Hemorrhage/blood loss/bleeding121.5%
Hypersensitivity/allergic reaction60.8%
Numbnessnumbness50.6%
Abscessa collection of pus40.5%
Fistula20.3%
Sinus perforation10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAXIOM IMPLANT ?5.2 x 8.0Product code DZEAll MAUDE reports
Reports7833,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about AXIOM IMPLANT ?5.2 x 8.0 reports

How many FDA reports name AXIOM IMPLANT ?5.2 x 8.0?

783 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 118 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (84%), loss of osseointegration (15.1%), fracture (2.4%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that AXIOM IMPLANT ?5.2 x 8.0 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.